Cargando…
Diagnosing melanoma patients entering American Joint Committee on Cancer stage IV, C-reactive protein in serum is superior to lactate dehydrogenase
Lactate dehydrogenase (LDH) in serum has recently been introduced into the American Joint Committee on Cancer (AJCC) staging system for cutaneous melanoma because of its prognostic value. We hypothesised LDH to be of value in discriminating melanoma patients entering AJCC stage IV from patients stay...
Autores principales: | Deichmann, M, Kahle, B, Moser, K, Wacker, J, Wüst, K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364774/ https://www.ncbi.nlm.nih.gov/pubmed/15280926 http://dx.doi.org/10.1038/sj.bjc.6602043 |
Ejemplares similares
-
American joint committee on cancer staging of uveal melanoma
por: Mellen, Phoebe L., et al.
Publicado: (2013) -
Regulating tumor glycometabolism and the immune microenvironment by inhibiting lactate dehydrogenase with platinum(iv) complexes
por: Jin, Suxing, et al.
Publicado: (2023) -
Prognostic Value of Lactate Dehydrogenase, Melanoma Inhibitory Protein, and S-100B Protein in Patients with Malignant Melanoma
por: Fan, Shuwen, et al.
Publicado: (2022) -
Retracted: Prognostic Value of Lactate Dehydrogenase, Melanoma Inhibitory Protein, and S-100B Protein in Patients with Malignant Melanoma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Prognostic value of lactate dehydrogenase in patients with uveal melanoma treated with immune checkpoint inhibition
por: Liang, Xiaocui, et al.
Publicado: (2023)